Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Force-dependent allostery of the α-catenin actin-binding domain controls adherens junction dynamics and functions.

Ishiyama N, Sarpal R, Wood MN, Barrick SK, Nishikawa T, Hayashi H, Kobb AB, Flozak AS, Yemelyanov A, Fernandez-Gonzalez R, Yonemura S, Leckband DE, Gottardi CJ, Tepass U, Ikura M.

Nat Commun. 2018 Nov 30;9(1):5121. doi: 10.1038/s41467-018-07481-7.

2.

Deletion of the glucocorticoid receptor chaperone FKBP51 prevents glucocorticoid-induced skin atrophy.

Baida G, Bhalla P, Yemelyanov A, Stechschulte LA, Shou W, Readhead B, Dudley JT, Sánchez ER, Budunova I.

Oncotarget. 2018 Oct 5;9(78):34772-34783. doi: 10.18632/oncotarget.26194. eCollection 2018 Oct 5.

3.

α-Catenin homodimers are recruited to phosphoinositide-activated membranes to promote adhesion.

Wood MN, Ishiyama N, Singaram I, Chung CM, Flozak AS, Yemelyanov A, Ikura M, Cho W, Gottardi CJ.

J Cell Biol. 2017 Nov 6;216(11):3767-3783. doi: 10.1083/jcb.201612006. Epub 2017 Sep 5.

4.

FXYD5 Is an Essential Mediator of the Inflammatory Response during Lung Injury.

Brazee PL, Soni PN, Tokhtaeva E, Magnani N, Yemelyanov A, Perlman HR, Ridge KM, Sznajder JI, Vagin O, Dada LA.

Front Immunol. 2017 Jun 1;8:623. doi: 10.3389/fimmu.2017.00623. eCollection 2017.

5.

Nuclear α-catenin mediates the DNA damage response via β-catenin and nuclear actin.

Serebryannyy LA, Yemelyanov A, Gottardi CJ, de Lanerolle P.

J Cell Sci. 2017 May 15;130(10):1717-1729. doi: 10.1242/jcs.199893. Epub 2017 Mar 27.

6.

Discovery of Compound A--a selective activator of the glucocorticoid receptor with anti-inflammatory and anti-cancer activity.

Lesovaya E, Yemelyanov A, Swart AC, Swart P, Haegeman G, Budunova I.

Oncotarget. 2015 Oct 13;6(31):30730-44. doi: 10.18632/oncotarget.5078. Review.

7.

α-Catenin is an inhibitor of transcription.

Daugherty RL, Serebryannyy L, Yemelyanov A, Flozak AS, Yu HJ, Kosak ST, deLanerolle P, Gottardi CJ.

Proc Natl Acad Sci U S A. 2014 Apr 8;111(14):5260-5. doi: 10.1073/pnas.1308663111. Epub 2014 Mar 25.

8.

Paracrine activation of WNT/β-catenin pathway in uterine leiomyoma stem cells promotes tumor growth.

Ono M, Yin P, Navarro A, Moravek MB, Coon JS 5th, Druschitz SA, Serna VA, Qiang W, Brooks DC, Malpani SS, Ma J, Ercan CM, Mittal N, Monsivais D, Dyson MT, Yemelyanov A, Maruyama T, Chakravarti D, Kim JJ, Kurita T, Gottardi CJ, Bulun SE.

Proc Natl Acad Sci U S A. 2013 Oct 15;110(42):17053-8. doi: 10.1073/pnas.1313650110. Epub 2013 Sep 30.

9.

Combination of a selective activator of the glucocorticoid receptor Compound A with a proteasome inhibitor as a novel strategy for chemotherapy of hematologic malignancies.

Lesovaya E, Yemelyanov A, Kirsanov K, Popa A, Belitsky G, Yakubovskaya M, Gordon LI, Rosen ST, Budunova I.

Cell Cycle. 2013 Jan 1;12(1):133-44. doi: 10.4161/cc.23048. Epub 2012 Dec 19.

10.

Androgen receptor drives cellular senescence.

Mirochnik Y, Veliceasa D, Williams L, Maxwell K, Yemelyanov A, Budunova I, Volpert OV.

PLoS One. 2012;7(3):e31052. doi: 10.1371/journal.pone.0031052. Epub 2012 Mar 5.

11.

Differential targeting of androgen and glucocorticoid receptors induces ER stress and apoptosis in prostate cancer cells: a novel therapeutic modality.

Yemelyanov A, Bhalla P, Yang X, Ugolkov A, Iwadate K, Karseladze A, Budunova I.

Cell Cycle. 2012 Jan 15;11(2):395-406. doi: 10.4161/cc.11.2.18945. Epub 2012 Jan 15.

12.

Antitumor effect of non-steroid glucocorticoid receptor ligand CpdA on leukemia cell lines CEM and K562.

Lesovaya EA, Yemelyanov AY, Kirsanov KI, Yakubovskaya MG, Budunova IV.

Biochemistry (Mosc). 2011 Nov;76(11):1242-52. doi: 10.1134/S000629791111006X.

PMID:
22117551
13.

Targeting transcription factor NFkappaB: comparative analysis of proteasome and IKK inhibitors.

Gasparian AV, Guryanova OA, Chebotaev DV, Shishkin AA, Yemelyanov AY, Budunova IV.

Cell Cycle. 2009 May 15;8(10):1559-66. Epub 2009 May 13.

PMID:
19372735
14.

Novel steroid receptor phyto-modulator compound a inhibits growth and survival of prostate cancer cells.

Yemelyanov A, Czwornog J, Gera L, Joshi S, Chatterton RT Jr, Budunova I.

Cancer Res. 2008 Jun 15;68(12):4763-73. doi: 10.1158/0008-5472.CAN-07-6104.

15.

Epithelial cells in the hair follicle bulge do not contribute to epidermal regeneration after glucocorticoid-induced cutaneous atrophy.

Chebotaev DV, Yemelyanov AY, Lavker RM, Budunova IV.

J Invest Dermatol. 2007 Dec;127(12):2749-58. Epub 2007 Jul 26.

16.

The mechanisms of tumor suppressor effect of glucocorticoid receptor in skin.

Chebotaev D, Yemelyanov A, Budunova I.

Mol Carcinog. 2007 Aug;46(8):732-40. Review.

PMID:
17538956
17.

Androgen receptor targets NFkappaB and TSP1 to suppress prostate tumor growth in vivo.

Nelius T, Filleur S, Yemelyanov A, Budunova I, Shroff E, Mirochnik Y, Aurora A, Veliceasa D, Xiao W, Wang Z, Volpert OV.

Int J Cancer. 2007 Sep 1;121(5):999-1008.

18.

The tumor suppressor effect of the glucocorticoid receptor in skin is mediated via its effect on follicular epithelial stem cells.

Chebotaev D, Yemelyanov A, Zhu L, Lavker RM, Budunova I.

Oncogene. 2007 May 10;26(21):3060-8. Epub 2006 Dec 4.

PMID:
17146443
19.

Tumor suppressor activity of glucocorticoid receptor in the prostate.

Yemelyanov A, Czwornog J, Chebotaev D, Karseladze A, Kulevitch E, Yang X, Budunova I.

Oncogene. 2007 Mar 22;26(13):1885-96. Epub 2006 Oct 2.

PMID:
17016446
20.

[Experience in using pump therapy and a glycemia monitoring system in diabetological care].

Yemelyanov AO.

Probl Endokrinol (Mosk). 2006 Jun 15;52(3):10-12. doi: 10.14341/probl200652310-12. Russian.

PMID:
31627504
21.

Effects of IKK inhibitor PS1145 on NF-kappaB function, proliferation, apoptosis and invasion activity in prostate carcinoma cells.

Yemelyanov A, Gasparian A, Lindholm P, Dang L, Pierce JW, Kisseljov F, Karseladze A, Budunova I.

Oncogene. 2006 Jan 19;25(3):387-98.

PMID:
16170348
22.

Photophysical properties of xanthophylls in carotenoproteins from human retinas.

Billsten HH, Bhosale P, Yemelyanov A, Bernstein PS, Polívka T.

Photochem Photobiol. 2003 Aug;78(2):138-45.

PMID:
12945581
23.

Low-Molecular Collagen Peptides Have Different Effects on Peritoneal Macrophages and Neutrophils.

Kozlov IG, Yemelyanov AY, Davidova NV, Gorlina NK, Cheredeev AN.

Russ J Immunol. 1999 Jul;4(2):113-122.

PMID:
12687118
24.

CD Antigens: Review of Data Obtained by April' 98.

Kozlov IG, Yemelyanov AY.

Russ J Immunol. 1998 Jul;3(2):107-132.

PMID:
12687090
25.

Low Molecular Weight Collagen Peptides Affect Migration, Proliferation and Apoptosis of Mouse Spleen Lymphocytes.

Yemelyanov AY, Kozlov IG, Gorlina NK, Poromov VM, Davuidova NV, Cheredeev AN.

Russ J Immunol. 1998 Apr;3(1):69-78.

PMID:
12687088
26.

Selenium compounds inhibit I kappa B kinase (IKK) and nuclear factor-kappa B (NF-kappa B) in prostate cancer cells.

Gasparian AV, Yao YJ, Lü J, Yemelyanov AY, Lyakh LA, Slaga TJ, Budunova IV.

Mol Cancer Ther. 2002 Oct;1(12):1079-87.

27.

Vitamin A in the cerebrospinal fluid of patients with and without idiopathic intracranial hypertension.

Warner JE, Bernstein PS, Yemelyanov A, Alder SC, Farnsworth ST, Digre KB.

Ann Neurol. 2002 Nov;52(5):647-50.

PMID:
12402264
28.
29.

Dynamics and Mechanisms of Interaction of Mouse Spleen Lymphocytes with 3D Collagen Matrix in vitro.

Kozlov IG, Gorlina NK, Yemelyanov AY, Kozlov EA, Cheredeev AN.

Russ J Immunol. 1997 Apr;2(1):41-48.

PMID:
12687054

Supplemental Content

Loading ...
Support Center